Disinformation by pharmaceutical industry undermines drug price reform

Canada’s drug prices are the fourth highest in the developed world. New guidelines aimed at lowering prescription drug prices have been in process for more than 2 years, and have met with intense pressure by the industry lobby group, Innovative Medicines Canada. Dr. Joel Lexchin examines the lies and half-truths put out by IMC. Lexchin is Professor Emeritus of Health Policy and Management at York University.